Search Results 41-50 of 12031 for immunothérapie effets secondaires

  1. Overview - Immunometabolism and Cancer Immunology Laboratory - Mayo Clinic Research

    The Immunometabolism and Cancer Immunology Lab of Marion R. Curtis, Ph.D., at Mayo Clinic studies the tumor microenvironment for ovarian cancer immunotherapy.

  2. A Study To Test The Addition Of The Immunotherapy Drug Pembrolizumab To The Usual Chemotherapy Treatment (Paclitaxel And Carboplatin) In Stage III-IV Or Recurrent Endometrial Cancer - Mayo Clinic

    Paclitaxel and carboplatin are chemotherapy drugs used as part of the usual treatment approach for this type of cancer. This study aims to assess if adding ...

  3. Researchers discover immune 'off switch' used by cancer cells

    ... immunotherapy. Their findings suggest that therapies designed to block TRAILshort could improve CAR-T treatment and potentially benefit other immune-based ...

  4. Allergy shots - Mayo Clinic

    The shots are given as a series that lasts 3 to 5 years. Allergy shots are a form of treatment called immunotherapy. Each allergy shot contains a tiny amount of ...

  5. Immune Monitoring And Immunotherapy In Myeloma - Mayo Clinic

    About this study. Characterize and identify the immune phenotype of patients with multiple myeloma by flow cytometry of peripheral blood circulating and ...

  6. Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers

    PHOENIX — A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect ...

  7. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

    The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which ...

  8. Impact Of Immunotherapy On Vestibular Function, The Mayo Clinic Arizona Experience

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer - Mayo Clinic

    Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck ...

  10. Novel SEQUEnced Immunotherapy With Anti-angiogenesis And Chemotherapy In Advanced GastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...